<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                                                                                                                                                EMBO <br />                                                                                                                                                  open <br />  <br />  <br />  <br />  <br />                                                                                  scientific report <br />                                                                                  scientificreport <br />  <br />      Role RNA/DNA kinase Grc3 transcription <br />      termination RNA polymerase I <br />      Priscilla Braglia1*, Katrin Heindl2*, Alexander Schleiffer3, Javier Martinez2+ &amp; Nick J. Proudfoot1++ <br />      1SirWilliam Dunn School Pathology, University Oxford, Oxford, UK, 2Institute Molecular Biotechnology Austrian <br />      Academy Sciences, 3Department Bioinformatics, Research Institute Molecular Pathology/Institute Molecular <br />      Biotechnology Austrian Academy Sciences, Vienna, Austria <br />  <br />             This open-access article distributed terms Creative Commons Attribution Noncommercial No Derivative Works 3.0 <br />             Unported License, permits distribution reproduction medium, provided original author source credited. This <br />             license does permit commercial exploitation creation derivative works specific permission. <br />  <br />  <br />  <br />      Transcription termination RNA polymerase I Saccharo-                              35S pre-rRNA, generates free 50 -end downstream <br />      myces cerevisiae mediated &#226;&#8364;&#732;torpedo&#226;&#8364;&#8482; mechanism:                                  Pol I-associated 30 -transcript. This acts substrate the <br />      co-transcriptional RNA cleavage Rnt1 ribosomal DNA                            50 &#226;&#8364;&#8220;30 exonuclease Rat1 degrades 30 -transcript. This <br />      30 -region generates 50 -end recognized 50 &#226;&#8364;&#8220;30                         process associated destabilization transcription <br />      exonuclease Rat1; degrades downstream transcript                           complex consequent termination (El Hage et al, 2008; <br />      eventually causes termination. In study, identify Grc3                     Kawauchi et al, 2008). <br />      new factor involved process. We demonstrate GRC3,                              Eukaryotic Clp1 component messenger RNA (mRNA) <br />      essential gene previously unknown function, encodes                             cleavage polyadenylation machinery (Minvielle-Sebastia <br />      polynucleotide kinase required efficient termination                     et al, 1997; Vries et al, 2000). Human Clp1 (hClp1) been <br />      RNA polymerase I. We propose controls phosphory-                            identified RNA kinase phosphorylates 50 -end both <br />      lation status downstream Rnt1 cleavage product                       synthetic short interfering RNAs transfer RNA (tRNA) 30 -exons <br />      regulates accessibility torpedo Rat1.                                        tRNA splicing (Weitzer &amp; Martinez, 2007). A potential <br />      Keywords: Grc3; kinase; Pol I; transcription termination                                enzymatic role hClp1 Pol II transcription termination has <br />      EMBO reports (2010) 11, 758&#226;&#8364;&#8220;764. doi:10.1038/embor.2010.130                             proposed, acts maintain 50 -phosphate on <br />                                                                                              downstream cleavage product generated mRNA 30 -end <br />      INTRODUCTION                                                                            processing. This provide Rat1 (Xrn2 mammals) a <br />      The enzyme RNA polymerase (Pol) I dedicated synthesis                         favourable substrate exonucleolytic degradation consequent <br />      ribosomal RNA (rRNA). Despite using distinct transcription                           Pol II termination (Weitzer &amp; Martinez, 2007). <br />      systems, Pol I Pol II close parallels process                            Although human protein RNA kinase, activity <br />      transcription termination (El Hage et al, 2008; Kawauchi et al,                         identified Saccharomyces cerevisiae Clp1 (Noble <br />      2008), terminate &#226;&#8364;&#732;torpedo&#226;&#8364;&#8482; mechanism                                  et al, 2007; Ramirez et al, 2008). A polynucleotide kinase-active <br />      (Kim et al, 2004; West et al, 2004). On ribosomal DNA (rDNA),                           Clp1 characterized Archaea, suggesting ancestral <br />      co-transcriptional cleavage transcript Rnt1 releases                      Clp1 possessed enzymatic activity ( Jain &amp; Shuman, 2009). It is <br />                                                                                              possible activity lost yeast evolution, the <br />      1 <br />       Sir William Dunn School Pathology, University Oxford, South Parks Road,          tRNA ligase Trl1 intrinsic kinase activity. <br />      Oxford OX1 3RE, UK                                                                          We looked potential RNA kinases yeast are <br />      2 <br />       Institute Molecular Biotechnology Austrian Academy Sciences,              functionally related Clp1. <span id='am-3' about='protege:FROM' typeof='owl:Thing'>From</span> work, identified Grc3 <br />      Dr. Bohr-Gasse 3, and <br />      3Department Bioinformatics, Research Institute Molecular Pathology/Institute   bioinformatic analysis (Supplementary Fig S1 online). <br />      Molecular Biotechnology Austrian Academy Sciences, Dr Bohr-Gasse 7-A,             GRC3 essential gene S. cerevisiae transcription <br />      Vienna 1030, Austria                                                                    cell cycle regulated (El-Moghazy et al, 2000), function <br />      *These authors contributed equally work <br />      + <br />        Corresponding author. Tel: &#195;&#190; 43 1 79044 4840; Fax: &#195;&#190; 43 1 79044 110; <br />                                                                                              unknown. A genome-wide study shown Grc3 is <br />      E-mail: javier.martinez@imba.oeaw.ac.at                                                 associated rRNA processing, particular the <br />      ++ <br />         Corresponding author. Tel: &#195;&#190; 44 1865 275566; Fax: &#195;&#190; 44 1865 275556;                  removal internal transcribed sequence 2 (ITS2; Peng et al, <br />      E-mail: nicholas.proudfoot@path.ox.ac.uk                                                2003). Grc3 observed, ribosomal proteins, <br />      Received 19 March 2010; revised 2 August 2010; accepted 3 August 2010;                  protein fraction isolated affinity purification of <br />      published online 3 September 2010                                                       Rai1 (Sydorskyy et al, 2003), co-purifies enhances <br />  <br />  <br /> 7 5 8 EMBO reports    VOL 11 | NO 10 | 2010                                                                 &amp;2010 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION <br />  Grc3 polynucleotide kinase Pol I termination <br /> P. Braglia et al                                                                                   scientific report <br /> Rat1 exoribonuclease activity (Xue et al, 2000; Xiang et al, 2009).           A                        P-loop <br /> Interestingly, pyrophosphatase activity identified           Grc3_Sc                                                  632 aa <br /> Schizosaccharomyces pombe Rai1 (Xiang et al, 2009). <br />     These molecular connections led investigate possible              Clp1_Sc                                                  445 aa <br /> role Grc3 Pol I transcription termination. In particular, we <br /> considered possibility phosphorylation status             Clp1_Hs                                                  425 aa <br /> 50 -end generated Rnt1 cleavage rRNA fine-tuned RNA <br /> kinase phosphatase activities. Rat1 closely related <span id='am-4' about='protege:TO' typeof='owl:Thing'>to</span> <br />                                                                                      B            T4 PNK               GST-Grc3 <br /> the exonuclease Xrn1 (Kenna et al, 1993), preferentially <br />                                                                                               0   3    30 60       0     3   30 60 min <br /> hydrolyses substrates 50 -monophosphate end (Stevens, <br /> 1980). This end normally generated RNase III-like activity                                                                  5&#226;&#8364;&#178;OH <br />                                                                                      ssRNA <br /> of Rnt1 (Gan et al, 2008) modifying enzymes                                                                      5&#226;&#8364;&#178;P <br /> be involved. <br />                                                                                                   T4 PNK               GST-Grc3 <br />     In study, Grc3 polynucleotide kinase, is <br />                                                                                               0    3   30 60       0     3   30 60 min <br /> present rDNA inactivation reduces efficiency of <br /> termination Pol I. We propose Grc3 kinase activity                        dsRNA                                            5&#226;&#8364;&#178;OH <br /> required maintain phosphorylated status downstream                                                                      5&#226;&#8364;&#178;P <br /> Rnt1 cleavage product, turn allows torpedo activity <br />                                                                                                   T4 PNK               GST-Grc3 <br /> of Rat1 efficiently terminate Pol I transcription. <br />                                                                                               0   3    30 60       0    3    30 60   min <br />  <br /> RESULTS                                                                                                                               5&#226;&#8364;&#178;OH <br />                                                                                      ssDNA <br /> Grc3 polynucleotide kinase                                                                                                       5&#226;&#8364;&#178;P <br /> In S. cerevisiae, polynucleotide kinase activity                                      T4 PNK               GST-Grc3 <br /> identified tRNA ligase Trl1. Although hClp1 RNA                              0   3 30 60          0     3   30 60   min <br /> kinase, yeast Clp1 lacks kinase activity ( J. Martinez, unpublished <br />                                                                                                                                       5&#226;&#8364;&#178;OH <br /> results; Noble et al, 2007; Ramirez et al, 2008). Performing                         dsDNA <br />                                                                                                                                       5&#226;&#8364;&#178;P <br /> National Center Biotechnology Information&#226;&#8364;&#8220;protein basic local <br /> alignment search tool (NCBI&#226;&#8364;&#8220;BLASTP) searches NCBI <br />                                                                        Fig 1 | Grc3 polynucleotide kinase. (A) Domain architecture <br /> non-redundant database, identified protein families related <br />                                                                        Clp1 Grc3. The Clp1 domain architecture derived from <br /> to Clp1 orthologues (Supplementary Fig S1 online): group of <br />                                                                        Noble et al (2007) transferred Grc3 using alignment. <br /> hypothetical proteins Eubacteria Archaebacteria a <br />                                                                        The central kinase domain depicted dark grey, carboxy- <br /> eukaryotic protein family including S. cerevisiae Grc3. These <br />                                                                        terminal domain light grey. Location P-loop/Walker A box is <br /> proteins share carboxy-terminal domain unknown function <br />                                                                        indicated rectangle. (B) Kinase assays glutathione-S-transferase <br /> and central nucleotide-binding domain containing highly <br />                                                                        (GST)-tagged Grc3. Purified Grc3 incubated indicated <br /> conserved structural element NTPase fold, P-loop/ <br />                                                                        substrates (single- double-stranded RNA DNA) indicated <br /> Walker A box (Fig 1A). <br />                                                                        time. Grc3 active RNA single-stranded DNA substrates. <br />    To determine yeast Grc3 kinase activity, we <br />                                                                        T4 polynucleotide kinase (PNK) assayed parallel control. <br /> expressed purified glutathione-S-transferase-tagged <br />                                                                        Phosphorylation monitored electrophoresis. aa, amino acid; <br /> protein performed vitro kinase assay using radiolabelled <br />                                                                        ds, double-stranded; Hs, Homo sapiens; Sc, Saccharomyces cerevisiae; <br /> single- double-stranded RNA DNA substrates (Fig 1B). <br />                                                                        ss, single-stranded. <br /> As positive control, tested T4 polynucleotide kinase in <br /> parallel. Phosphorylation detected mobility shift on <br /> a polyacrylamide denaturing gel. As shown Fig 1B, Grc3 <br /> displayed polynucleotide kinase activity single- and <br /> double-stranded RNA single-stranded DNA alone,          terminator region (2 6&#195;&#190;7). No significant enrichment was <br /> double-stranded DNA alone. Therefore, results support        detected upstream transcription start site further <br /> bioinformatic analysis confirm Grc3 polynucleotide       downstream 35S 30 -regions (US5S 8). ChIP signals <br /> kinase.                                                                relatively low reproducible, consistent transient <br />                                                                        association Grc3 chromatin enzyme involved in <br /> Grc3 ChIPs rRNA encoding terminator regions                     rRNA processing. However, presence Grc3 the <br /> Genome-wide studies suggest Grc3 involved rRNA              terminator region prompted test Grc3 in- <br /> processing (Peng et al, 2003), implies present        volved 35S 30 -processing and/or Pol I transcription termination. <br /> in nucleolus. To determine protein recruited <br /> onto rDNA, prepared 3   haemagglutinin (3HA&#226;&#8364;&#8220;GRC3)-tagged          Grc3 depletion stabilizes 30 -ETS Pol I transcripts <br /> strain performed chromatin immunoprecipitation (ChIP)              We determined levels 30 -external transcribed <br /> analysis Pol I transcription <span id='am-1' about='Thesaurus:Unit' typeof='owl:Thing'>unit</span>. As control,    sequence (ETS) transcripts influenced Grc3 using strain <br /> probed coding region ISY1, Pol II-transcribed gene.           GRC3 control regulatable promoter <br /> ChIP signals detected background rDNA            (Tet Off). The addition doxycycline severely affected cell <br /> gene (Fig 2A,B; regions 18,2 25,3),            growth GRC3 mRNA levels dropped 20% the <br />  <br />  <br /> &amp;2010 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION                                                                   EMBO reports VOL 11 | NO 10 | 2010 7 5 9 <br />       scientific report                                                                                                                                                                 Grc3 polynucleotide kinase Pol I termination <br />                                                                                                                                                                                                                         P. Braglia et al <br />  <br />  <br />  <br />  <br />                      A <br />                          RT&#226;&#8364;&#8220;PCR                                                                                                                          p0          p1    p2 p3             p4     p5            p6 <br />                           oligos                                                                35S <br />                                             Reb1 <br />                                                                            18S             5.8S                                  25S                                                                         5S <br />                                                                                                                                                          T1               T2                                           ARS <br />                                                   5&#226;&#8364;&#178; ETS                                ITS1      ITS2                                             3&#226;&#8364;&#178; ETS <br />                           ChIP <br />                           oligos    US5S                                    18,2                                                            25,3     2                         6+7                  8 <br />  <br />  <br />                           TRO                                                                                                                            2       3 <br />                          probes             Pro                                                                                                                       4        5       6    7 <br />  <br />                                                            B               Grc3 ChIP <br />  <br />                                                                            0.16 <br />                                                             IP (% input) <br />  <br />  <br />  <br />  <br />                                                                            0.12 <br />  <br />                                                                            0.08 <br />  <br />                                                                            0.04 <br />  <br />                                                                              0 <br />                                                                                    US5S        18,2      25,3                          2           6+7           8                         ISY1 <br />  <br />                                                    C       RT&#226;&#8364;&#8220;PCR <br />                                                                                                       WT                                                         Tet Off-GRC3 <br />                                                                  M           &#226;&#8364;&#8220;     -RT p1       p2    p3    p4                        p5     p6 -RT p1               p2    p3      p4        p5     p6 <br />  <br />  <br />  <br />  <br />                            D                                                                                                          100                                                                         WT GRC3 <br />                                       TRO <br />                                                                                                                 Relative TRO signal <br />  <br />  <br />  <br />  <br />                                                                                                                                        80                                                                         Tet Off-GRC3 <br />  <br />                                WT <br />                                                                                                                                        60 <br />  <br />                                        2      3        4            5        6      7     Pro Act                                      40 <br />  <br />                           Tet Off &#226;&#8364;&#8220;                                                                                                    20 <br />                            GRC3 <br />                                                                                                                                         0 <br />                                                                                                                                                2             3        4            5            6        7                   Act <br />  <br />  <br />      Fig 2 | Grc3 depletion results defective transcription termination RNA polymerase I. (A) Schematic Saccharomyces cerevisiae rDNA repeat. <br />      In addition sequence encoding 18S, 5.8S 25S rRNA (grey rectangles), Pol I transcription <span id='am-2' about='Thesaurus:Unit' typeof='owl:Thing'>unit</span> includes ETSs ITSs; 35S primary <br />      transcript shown dashed arrow. Grey ovals denote binding sites Reb1, triangle denotes Rnt1 cleavage site vertical arrows indicate <br />      T1 T2 terminator elements. 5S rDNA, transcribed Pol III opposite orientation, ARS shown. Primers used RT&#226;&#8364;&#8220;PCR shown <br />      above, chromatin immunoprecipitation (ChIP) oligonuleotides TRO probes below. (B) ChIP analysis 3HA-tagged Grc3 rDNA. Specific <br />      enrichment (above dashed line) visible rRNA encoding terminator sequence. Pol II-transcribed ISY1 shown control. An average <br />      independent experiments shown, error bars indicate s.d. values. (C) RT&#226;&#8364;&#8220;PCR analysis transcripts downstream Rnt1 cleavage site <br />      WT Grc3-depleted (Tet Off-GRC3) cells. Reverse transcription primed oligonuleotides p1&#226;&#8364;&#8220;p6, PCR common forward primer <br />      p0 indicated reverse primers. Grc3 depletion results stabilization Pol I transcripts 35S 30 -region. Oligonucleotide p1 <br />      reverse transcriptase ( RT) cDNA used template control PCR reactions. M, molecular weight marker (Invitrogen <br />      1 kb Plus). (D) TRO analysis Pol I transcripts 35S 30 -region WT Tet Off-GRC3 cells. Grc3 depletion results Pol I termination <br />      defect. Quantification signals shown right-hand panel. Background signal (Pro) subtracted probe value. Data then <br />      normalized probe 2, set 100%. The Pol II-transcribed actin gene (Act) shown control. The average independent experiments <br />      shown, error bars indicate s.d. values. ARS, autonomously replicating sequence; ETS, external transcribed sequence; HA, haemagglutinin; ITS, <br />      internal transcribed sequence; RT&#226;&#8364;&#8220;PCR, reverse transcriptase PCR; rDNA, ribosomal DNA; rRNA, ribosomal RNA; TRO, transcriptional run on; <br />      WT, wild type. <br />  <br />  <br /> 7 6 0 EMBO reports   VOL 11 | NO 10 | 2010                                                                                                                           &amp;2010 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION <br />  Grc3 polynucleotide kinase Pol I termination <br /> P. Braglia et al                                                                                   scientific report <br /> wild-type (WT) level 5 h (data shown). We extracted total      <span id='am-83' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-84' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-89' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-95' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-96' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-99' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-125' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-128' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-137' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-145' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-160' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span>mutation</span> strongly affected cell growth, severely, <br /> RNA WT Tet Off-GRC3 cells, performed reverse                     confirming mutated critical residues Grc3 <br /> transcription oligonucleotides p1&#226;&#8364;&#8220;p6 (Fig 2A) PCR          active site. <br /> the oligonucleotides common forward primer p0,                    Next, tested Pol I transcription termination K252A <br /> annealing downstream Rnt1 cleavage site. With method         mutant TRO (Fig 3C). The S253A mutant severely <br /> we detected transcripts produced Pol I downstream main         growth-retarded allow analysis. However, quantitative <br /> terminator element T1. On rDNA, small proportion polymerases        analysis K252A produced Pol I termination profile similar to <br /> read signal, terminating downstream T2        obtained Grc3 depletion. Thus, clear termination <br /> element (Lang et al, 1994; El Hage et al, 2008). In WT strain,       defect (higher polymerase density probes 3&#226;&#8364;&#8220;7) obtained, <br /> reverse transcriptase PCR (RT&#226;&#8364;&#8220;PCR) signal detectable oligo-     strongly suggesting kinase activity Grc3 required for <br /> nucleotide p1 (upstream T2), weak p2 present        efficient termination. We conclude Grc3 polynucleotide <br /> at downstream (Fig 2C; left). By contrast, depletion   kinase activity important role determining efficient <br /> Grc3, 30 -extended transcripts visible (oligonucleotides            termination Pol I. <br /> p2&#226;&#8364;&#8220;p5), 5S gene (Fig 2C; right). We conclude Grc3 <br /> is involved Pol I transcription termination stabilization    DISCUSSION <br /> 30 -transcripts extend normal termination site.          We shown Grc3, essential yeast protein previously <br />                                                                          unknown function, polynucleotide kinase similarities to <br /> Grc3 depletion causes defective Pol I termination                        Clp1. Furthermore, enzyme physiological role <br /> Although RT&#226;&#8364;&#8220;PCR measures steady-state RNA levels, transcriptional        Pol I transcription termination, kinase-inactive Grc3 mutants <br /> run (TRO) analysis monitors nascent transcription and, thus,          produce increased read-through transcription rDNA 30 -ETS. <br /> provides map active polymerase density indicating              How polynucleotide kinase involved termination <br /> transcription termination occurs. Using TRO analysis,         process? Pol I transcription termination involves co-transcriptional <br /> compared WT Tet Off-GRC3 strains, using probes covering              RNA cleavage Rnt1, followed degradation down- <br /> the rDNA terminator region (outlined Fig 2A). As control,        stream cleavage product 50 &#226;&#8364;&#8220;30 exonuclease Rat1. This <br /> also used probe upstream Pol I transcriptional start site       &#226;&#8364;&#732;torpedoes&#226;&#8364;&#8482; Pol I eventually causes termination releasing it <br /> (Pro), providing background signal, actin gene (Act),       DNA template (El Hage et al, 2008; Kawauchi et al, <br /> transcribed Pol II. All data quantified relative probe 2,     2008). The phosphorylation status downstream Rnt1 <br /> overlapping T1 terminator, previously described (Jones et al,     cleavage product critical role recognition by <br /> 2007). In WT, obtained expected termination profile        Rat1. Substrates 50 -monophosphate ends strongly <br /> strong signal probe 2, reduced signal probe 3 near         preferred non-phosphorylated 50 -ends 50 &#226;&#8364;&#8220;30 exonuclease <br /> to background signal downstream (Fig 2D). On depletion Grc3,          Xrn1 (Stevens, 1980). It likely Rat1, closely related Xrn1, <br /> we observed proportionally higher signal downstream           similar specificity. We propose Grc3 acts maintain the <br /> probes (3&#226;&#8364;&#8220;7), indicating termination defect. We conclude          phosphorylated status downstream RNA Rnt1 <br /> not RNA stability, Pol I termination itself affected    cleavage, possibly counteracting phosphatase activity (Fig 4). <br /> by loss Grc3.                                                     This equilibrium regulate kinetic overall efficiency <br />                                                                          transcription termination Pol I. In support model, <br /> Pol I termination requires Grc3 kinase activity                          Grc3 observed immunoprecipitate Rai1, the <br /> Next, aimed determine effect Grc3 Pol I          Rat1-activating partner (Sydorskyy et al, 2003). Previous results <br /> termination mediated polynucleotide kinase activity.           connected Grc3 rRNA processing (Peng et al, 2003). <br /> We mutated specific conserved residues Walker A box            Interestingly, Rat1 RNA exonuclease involved in <br /> Grc3, based sequence homology hClp1. In particular,          50 -trimming rRNA-processing intermediates (Kufel et al, 1999). <br /> we produced K252A S253A mutants correspond-              Therefore, studies predict functional coupling these <br /> ing mutations abolish kinase activity hClp1 (Weitzer &amp;            activities. <br /> Martinez, 2007). <br />    We assessed kinase activity mutants using purified         METHODS <br /> glutathione-S-transferase-tagged Grc3 (WT, K252A S253A)          Clp1/Grc3 protein family collection. hClp1 (NP_006822.1) was <br /> a mixture single- double-stranded RNA substrate            used query NCBI&#226;&#8364;&#8220;BLASTP searches NCBI non- <br /> kinase assay, before. The WT protein rapidly phosphorylated           redundant database (Altschul et al, 1997). To expand protein <br /> the RNA (Fig 3A), mutant K252A showed partial                family, significant hits (E-values o1   104) used queries in <br /> activity overnight incubation, S253A           searches. Selected proteins aligned using MUSCLE <br /> completely inactive.                                                     (Edgar, 2004). <br />    To test mutants vivo, replaced endogenous             Expression purification Grc3. The open reading frame of <br /> GRC3 promoter regulatable GAL1 promoter, repressed          Grc3 (WT, K252A S253A) cloned pDEST20 using the <br /> transcription glucose expressed Grc3, WT mutant forms,         Gateway technique (Invitrogen) expressed sf9 insect cells. <br /> from centromeric plasmid. As shown Fig 3B, control cells            After collection, cells lysed 100 mM NaCl, 50 mM <br /> transformed plasmid showed scarce growth,            Tris&#226;&#8364;&#8220;HCl (pH 8), 5 mM MgCl2, 0.1 mM 4-(2-aminoethyl) benzene- <br /> on plate liquid culture expected, GRC3              sulphonyl fluoride hydrochloride, 1 mM dithiothreitol soni- <br /> essential. Also transformation WT Grc3 produced viable cells        cated. Purification performed using glutathione Sepharose 4B <br /> with nearly normal growth <span id='am-5' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-6' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-7' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-12' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-31' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-36' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-40' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-44' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-46' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span>phenotype</span>. Both K252A S253A                (GE Healthcare). Protein eluted 20 mM glutathione, <br />  <br />  <br /> &amp;2010 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION                                                               EMBO reports VOL 11 | NO 10 | 2010 7 6 1 <br />       scientific report                                                                                                                                          Grc3 polynucleotide kinase Pol I termination <br />                                                                                                                                                                                                  P. Braglia et al <br />  <br />  <br />  <br />  <br />                               A     Mutant Grc3&#226;&#8364;&#8221;kinase assay <br />  <br />                                          GST-ScGrc3 WT                                         GST-ScGrc3 K252A                                    GST-ScGrc3 S253A <br />                                     0     3 10                   30       60 o/n           0       3 10   30             60 o/n                0      3 10         30   60 o/n <br />                                                                                                                                                                                      5&#226;&#8364;&#178;OH <br />  <br />                                                                                                                                                                                      5&#226;&#8364;&#178;P <br />  <br />                                         B Mutant grc&#226;&#8364;&#8221;growth                                                                                   Empty      WT        K252A     S253A <br />  <br />                                                                                1:10 dilutions <br />                                                                                                                                  6 <br />                                                                                                                                  5 <br />  <br />  <br />  <br />  <br />                                                                                                                OD595 t(x)/t(0) <br />                                                Empty <br />                                                                                                                                  4 <br />                                                                                                                                  3 <br />                                            GRC3 WT <br />                                                                                                                                  2 <br />                                                                                                                                  1 <br />                                           grc3 K252A <br />                                                                                                                                  0 <br />                                                                                                                                      0       100      200         300      400   500 <br />                                           grc3 S253A <br />                                                                                                                                                               t (min) <br />  <br />                                            C                           Mutant grc3&#226;&#8364;&#8221;TRO <br />  <br />  <br />                                                                                      WT <br />  <br />  <br />                                                                                                2     3    4                      5       6     7        Pro     Act <br />  <br />  <br />                                                                                    K252A <br />  <br />  <br />  <br />  <br />                                                                        100                                                                                              WT <br />                                                  Relative TRO signal <br />  <br />  <br />  <br />  <br />                                                                         80                                                                                              K252A <br />  <br />                                                                         60 <br />  <br />                                                                         40 <br />  <br />                                                                         20 <br />  <br />                                                                          0 <br />                                                                                2           3         4                 5                 6          7                      Act <br />  <br />      Fig 3 | Kinase-inactive Grc3 mutants defective cell growth RNA polymerase I termination. (A) Kinase assays WT mutant Grc3. <br />      Purified GST-tagged Grc3 (WT, K252A S253A) incubated 2:1 mixture single- double-stranded RNA indicated time <br />      (in min; o/n, overnight). Substrate phosphorylation monitored electrophoresis. Grc3 kinase activity strongly delayed K252A <br />      absent S253A mutant. (B) Growth phenotype cells expressing WT mutant Grc3 (K252A S253A) centromeric plasmid. <br />      Endogenous GRC3 transcription repressed glucose. Cell proliferation severely affected Grc3 mutation. Cells transformed an <br />      plasmid shown control. Left panel: serial dilutions drop plate. Right panel: growth curves liquid culture. (C) TRO analysis cells <br />      expressing WT K252A mutant Grc3. The kinase-inactive Grc3 mutant defective Pol I termination. Probes quantification Fig 2D. <br />      GST, glutathione-S-transferase; Pol I, RNA polymerase I; TRO, transcriptional run on; WT, wild type. <br />  <br />  <br />  <br />  <br />      concentrated Vivaspin 500 columns (Sartorius) dialysed                                             obtain 50 , 30 -hydroxylated RNA substrates. The DNA substrates <br />      30 mM 4-(2-hydroxyethyl)-1-piperazineethanesulphonic                                              labelled 32P cordycepin recombinant terminal <br />      acid (pH 7.4), 5 mM MgCl2, 100 mM KCl, 10% glycerol                                                   deoxynucleotidyl transferase (Promega). Phosphorylation was <br />      0.1 mM 4-(2-aminoethyl) benzenesulphonyl fluoride hydrochloride.                                          monitored 15% polyacrylamide/urea gel. <br />      In vitro kinase assay. Kinase assays performed described                                          Yeast strains plasmids. Strains used pGAL-3HA-GRC3 <br />      previously (Weitzer &amp; Martinez, 2007) presence 5 mM                                             (MAT-a; ade2-1; can1-100; his3-11,15; leu2-3,112; trp1-1; ura3-1; <br />      ATP 30 1C. Substrates 21-nucleotides long                                              PGAL1-3HA-GRC3 KANMX6) untagged W303-1a (MAT-a; ade2-1; <br />      single-stranded annealed complementary oligonucleotide                                            can1-100; his3-11,15; leu2-3,112; trp1-1; ura3-1) (Fig 2B) and <br />      create blunt double strands. The RNA substrates 30 -end-                                          WT R1158 (MAT-a; his3-1; leu2-0; met15-0; URAHCMV-tTA) and <br />      labelled 32P pCp using T4 RNA Ligase (Amersham)                                                  Tet Off-GRC3 (MAT-a; his3-1; leu2-0; met15-0; URAHCMV-tTA; <br />      dephosphorylated alkaline phosphatase (Roche)                                                kanR-tetO7-TATA-GRC3) (Fig 2C,D). GRC3 repressed by <br />  <br />  <br /> 7 6 2 EMBO reports   VOL 11 | NO 10 | 2010                                                                                                         &amp;2010 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION <br />  Grc3 polynucleotide kinase Pol I termination <br /> P. Braglia et al                                                                                                         scientific report <br />  <br />                                                                                                                    ll <br />                                                                                                                  Po <br />                                                                                                         ll                ll <br />                                                                                                       Po                Po <br />  <br />  <br />                                                                                                    Reb1 <br />                                          25s                                             ll                 ll <br />                                                       3&#226;&#8364;&#178; ETS     Rnt1               Po        T1          Po     T2 <br />                                                                cleavage <br />                                                                           P <br />                                                                        Rat1 <br />                                                                            P <br />                                            35S pre-rRNA <br />  <br />  <br />  <br />                                                         Phosphatase                Kinase <br />                                                              ?                      Grc3 <br />  <br />                                                                                                         ll <br />                                                                                                       Po <br />                                                                                                                                      ll <br />                                                                                                                                    Po <br />                                                                                                    Reb1 <br />                                            25S                                        ll                    ll               ll <br />                                                       3&#226;&#8364;&#178; ETS     Rnt1               Po        T1          Po      T2       Po <br />                                                                cleavage <br />                                                                           OH <br />  <br />  <br />                                                                               OH <br />  <br />                                            35S pre-rRNA <br />                                                                                OH <br />                                                                        Rat1 <br />  <br /> Fig 4 | Model Grc3 kinase activity involvement process transcription termination Pol I. Rnt1 co-transcriptionally cleaves transcript <br /> RNA stem loop structure 30 -ETS. The phosphorylation status Rnt1 cleavage 30 -product controlled equilibrium a <br /> putative phosphatase activity RNA kinase Grc3. The phosphorylated 50 -end (top) recognized 50 &#226;&#8364;&#8220;30 exonuclease Rat1 &#226;&#8364;&#732;torpedoes&#226;&#8364;&#8482; <br /> Pol I promotes transcription termination. When Grc3 absent inactive, equilibrium shifted 30 -transcripts present 50 -hydroxyl <br /> end (bottom). This suboptimal substrate &#226;&#8364;&#732;torpedo&#226;&#8364;&#8482; Rat1. As consequence, 30 -transcripts stabilized Pol I termination impaired. <br /> ETS, external transcribed sequence; Pol I, RNA polymerase I; rRNA, ribosomal RNA. <br />  <br />  <br />  <br />  <br /> treating cells 10 mg/ml doxycycline 5 h. pGAL-3HA-GRC3                 Supplementary information available EMBO reports online <br /> strain transformed modified pCM252 (lacking Tet-O                    (http://www.emboreports.org). <br /> box repeats) containing GRC3 open reading frame (WT mutant) <br /> cloned StuI site (Fig 3). Standard media growth conditions               ACKNOWLEDGEMENTS <br /> were used.                                                                          We thank F. Lampert S. Westermann Research Institute <br />                                                                                     Molecular Pathology, Vienna. This study supported a <br /> ChIP. The ChIP analysis performed described previously <br />                                                                                     Wellcome Trust Programme Grant N.J.P. Genomic Research <br /> (Kawauchi et al, 2008), using Anti-HA Clone F7 antibody                             Austria Fonds zur Fo&#194;&#168;rderung der wissenschaftlichen Forschung <br /> (Santa Cruz Biotechnology). Background signal untagged                     (grant P20502-B11) K.H. J.M. <br /> strain subtracted 3HA-GRC3 signal position. <br /> Oligonucleotide sequences described previously                            CONFLICT OF INTEREST <br /> (Kawauchi et al, 2008).                                                             The authors declare conflict interest. <br /> RT&#226;&#8364;&#8220;PCR. RT&#226;&#8364;&#8220;PCR performed Superscript III RT <br /> (Invitrogen) 400 ng RNA priming reaction mixture                      REFERENCES <br />                                                                                     Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ <br /> of oligonucleotides p1&#226;&#8364;&#8220;p6. A total 28 cycles PCR                              (1997) Gapped BLAST PSI-BLAST: new generation protein <br /> performed communal oligonulceotide p0    <br /> </body></html>